Zydus group refutes media report claiming suspension of Biotax sales in Nepal, says will sell antibiotic with 10ml sterile water

Zydus has supplied 5ml sterile water for injection along with the product but the direction for use states "use 3ml for intramuscular injection and 10ml for intravenous injection".

"The objection raised by the agency is only with reference to the non-supply of 10ml sterile water for injection along with the product," the statement said, adding that this does not have any impact on product quality nor does it pose any risk to patient safety as stated in the article.

For intramuscular injection, the product can be constituted with 3ml sterile water provided with the product. For intravenous injection, the product should be reconstituted by using 10ml sterile water for injection separately, it added.

Further, it said, "Based on the letter received from DDA Nepal, we are amending as per the agency's requirement, the product will be made available with 10ml sterile water for injection instead of 5ml so that the product can be administered for intramuscular as well as intravenous as per the patient's requirement."

Zydus group asserted that "no product complaint or any adverse event because of the usage of the product has been received from Nepal since the product commercialisation in 2018. The product Biotax 1g injection has been renewed every year as per DDA, Nepal regulation."

Read also: Zydus Lifesciences bags USFDA tentative nod for Azilsartan Medoxomil and Chlorthalidone Tablets for hypertension